StockData
Anebulo Pharmaceuticals, Inc. logo

Anebulo Pharmaceuticals, Inc. (ANEB) stock

ANEBNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026Score 0/30
$0.00+0.00 (+75.00%)

Close on Oct 19, 2026Market cap $28.76KP/E –Yield –

Anebulo Pharmaceuticals EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Anebulo Pharmaceuticals's EPS for the twelve months ending Dec 31, 2025 was -$0.19. For fiscal 2025 it was -$0.25. The highest annual figure on record is $0.29 in fiscal 2022.

Annual eps

PeriodPeriod endValueChange
FY2025Jun 30, 2025-$0.25–
FY2024Jun 30, 2024-$0.32–
FY2023Jun 30, 2023-$0.47-262.1%
FY2022Jun 30, 2022$0.29–
FY2021Jun 30, 2021-$2.83–

Quarterly eps

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ4 2025Dec 31, 2025-$0.05–
Q1 FY2026CQ3 2025Sep 30, 2025-$0.05–
Q4 FY2025CQ2 2025Jun 30, 2025-$0.05–
Q3 FY2025CQ1 2025Mar 31, 2025-$0.04–
Q2 FY2025CQ4 2024Dec 31, 2024-$0.09–
Q1 FY2025CQ3 2024Sep 30, 2024-$0.08–
Q4 FY2024CQ2 2024Jun 30, 2024-$0.05–
Q3 FY2024CQ1 2024Mar 31, 2024-$0.06–
Q2 FY2024CQ4 2023Dec 31, 2023-$0.11–
Q1 FY2024CQ3 2023Sep 30, 2023-$0.10–
Q4 FY2023CQ2 2023Jun 30, 2023-$0.10–
Q3 FY2023CQ1 2023Mar 31, 2023-$0.11–
Q2 FY2023CQ4 2022Dec 31, 2022-$0.15–
Q1 FY2023CQ3 2022Sep 30, 2022-$0.11–
Q2 FY2022CQ4 2021Dec 31, 2021-$0.05–
Q1 FY2022CQ3 2021Sep 30, 2021-$0.07–
Q4 FY2021CQ2 2021Jun 30, 2021-$1.77–
Q3 FY2021CQ1 2021Mar 31, 2021-$0.68–
Q2 FY2021CQ4 2020Dec 31, 2020-$0.03–
Q1 FY2021CQ3 2020Sep 30, 2020-$0.02–

More Anebulo Pharmaceuticals figures

See a number that looks wrong?